Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New implant could revolutionize stoma care for bowel patients

NCT ID NCT07413822

First seen Feb 22, 2026 · Last updated Jun 23, 2026 · Updated 20 times

Summary

This early study tests a new device called TIES®, which is surgically implanted to help people with permanent ileostomy or colostomy control when they empty their bowels. Ten adults will be followed for 16 weeks to see if the device is safe, works well, and improves their quality of life compared to standard stoma bags.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLOSTOMY - STOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

TIES® Transcutaneous Implant Evacuation System (a surgically implanted device)

What this could lead to

If it works, this could offer a more convenient and controlled way to manage bowel movements for people with permanent stomas, potentially improving their daily comfort and quality of life.

What could go wrong

This is a very early pilot study with only 10 participants, so results may not apply to everyone. The device requires surgery and carries risks like infection or implant failure, and it may not work as intended.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.